Withings has quietly become a home health superpower in recent years, despite a short partnership with Nokia. The French business may not be as well-known as Apple or Samsung, but it makes well-made equipment for important readings outside the doctor’s office.
BeamO, which seems like an ’80s toy, appears to be one of the company’s better healthcare products. Instead of a fitness watch or sleep tracker, Withings introduced a new category. The business calls the “multiscope” a device that helps patients access vitals during teleconference health calls.
In that light, the product makes sense. Telehealth visits increased 15 times during the epidemic, according to the U.S. government. As the globe opens, that number has likely decreased, but the simplicity and timeliness of a non-emergency in-office visit are undisputed. 
According to Withings, the system gives four health measures and is “smaller than a smartphone.” This supercharged digital thermometer also functions as an electrocardiogram, oximeter, and stethoscope, offering your doctor real-time information.
“Post-pandemic telemedicine is commonplace,” says CEO Eric Carrell. “While convenient and cost-effective, remote visits prevented health professionals from performing routine checks. BeamO, a technology that integrates four medical devices, will enable this remotely.
Withings claims the system can measure SpO2, heart rate, and ECG (“medical grade”) simultaneously and present relevant data. A USB-C to audio jack adaptor connects headphones to the system. The healthcare practitioner may get that audio via the app.
The technology needs FDA approval for AFib detection. Withings expects it to retail for $250 in July.
